{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:24:03Z","timestamp":1787747043628,"version":"build-2784847793"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"crossref","award":["2021R1A2C2011292"],"award-info":[{"award-number":["2021R1A2C2011292"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"crossref","award":["23B0104L1"],"award-info":[{"award-number":["23B0104L1"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Targeting METTL3 with the heat shock protein 90 inhibitor 17-DMAG mitigated kidney fibrosis in CKD.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The drug repositioning through differentially expressed gene and enrichment analyses identified 17-dimethylaminoethylamino-17-demethoxygeldanamycin as a potential agent to alleviate kidney fibrosis.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            The\n                            <jats:italic toggle=\"yes\">N<\/jats:italic>\n                            -terminal heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin suppressed c-Jun\u2013METTL3 signaling, attenuating\n                            <jats:italic toggle=\"yes\">N<\/jats:italic>\n                            6-methyladenosine methylation and kidney fibrosis.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Kidney fibrosis is a major pathological feature of CKD, characterized by excessive deposition of extracellular matrix proteins, leading to progressive loss of kidney function.\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      6-methyladenosine (m6A) RNA methylation has emerged as a crucial epigenetic modification implicated in various diseases, including kidney fibrosis. METTL3, an m6A writer, plays a key role in promoting fibrosis by stabilizing profibrotic gene expression. Therefore, targeting METTL3 represents a promising therapeutic strategy for CKD treatment. In this study, we explored the therapeutic potential of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in regulating METTL3 to mitigate kidney fibrosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Through transcriptome-based drug repositioning, we identified 17-DMAG as a potential inhibitor of METTL3. Differentially expressed gene analysis was performed to assess the enrichment of 17-DMAG in CKD-related gene expression profiles. The antifibrotic effects of 17-DMAG were evaluated in\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      models. The mechanism by which 17-DMAG downregulates METTL3 was also investigated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      17-DMAG significantly reduced METTL3 expression in renal epithelial cells in a dose-dependent and time-dependent manner. In\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      mouse models of kidney fibrosis, 17-DMAG treatment attenuated METTL3 levels, reduced total m6A modification, and effectively mitigated fibrosis, as evidenced by decreased collagen deposition and profibrotic marker expression. Mechanistically, 17-DMAG, a heat shock protein 90 (HSP90)\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      -terminal inhibitor, induced a heat shock response that sequentially upregulated HSP70 expression. The elevated HSP70 levels inhibited c-Jun\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      -terminal kinase activity, thereby suppressing the c-Jun transcription factor and ultimately leading to the downregulation of METTL3 expression. MeRIP-Seq analysis revealed that 17-DMAG reversed unilateral ischemia-reperfusion injury\u2013induced m6A epitranscriptomic changes in fibrosis-related genes, including\n                      <jats:italic toggle=\"yes\">GSK3B<\/jats:italic>\n                      , which is involved in fibrotic pathways.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      -terminal HSP90 inhibition, along with subsequent c-Jun suppression, contributed to the mechanism underlying 17-DMAG\u2013induced METTL3 downregulation. Through this regulatory pathway, 17-DMAG effectively suppressed METTL3 expression and attenuated kidney fibrosis in both\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      models.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1681\/asn.0000000975","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T17:00:16Z","timestamp":1769446816000},"page":"1404-1422","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Therapeutic Potential of Heat Shock Protein 90 Inhibitor 17-DMAG in Regulating METTL3 for Kidney Fibrosis Treatment"],"prefix":"10.1681","volume":"37","author":[{"given":"Soo Min","family":"Lee","sequence":"first","affiliation":[{"name":"College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea"},{"name":"Department of Biomedical and Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5285-4874","authenticated-orcid":false,"given":"Myoung Seok","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiology, Seoul National University Boramae Medical Center, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8307-2474","authenticated-orcid":false,"given":"Hae Rim","family":"Jung","sequence":"additional","affiliation":[{"name":"Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3199-635X","authenticated-orcid":false,"given":"Jeonghwan","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea"},{"name":"Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogyeong","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3640-0914","authenticated-orcid":false,"given":"Wencheng","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea"},{"name":"Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2448-2895","authenticated-orcid":false,"given":"Min Hoan","family":"Moon","sequence":"additional","affiliation":[{"name":"Department of Radiology, Seoul National University Boramae Medical Center, Seoul, Republic of Korea"},{"name":"Department of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9603-5077","authenticated-orcid":false,"given":"Nayeon","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5132-5452","authenticated-orcid":false,"given":"Seung Hyun","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Som","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bada","family":"Lee","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea"},{"name":"Department of Biomedical and Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6033-290X","authenticated-orcid":false,"given":"Seung-Pyo","family":"Hong","sequence":"additional","affiliation":[{"name":"Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea"},{"name":"Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Il","family":"Kim","sequence":"additional","affiliation":[{"name":"Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea"},{"name":"Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea"},{"name":"Cancer Research Institute, Seoul National University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9123-6542","authenticated-orcid":false,"given":"Chun Soo","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea"},{"name":"Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2720-6952","authenticated-orcid":false,"given":"Sung-Yup","family":"Cho","sequence":"additional","affiliation":[{"name":"Genomic Medicine Institute, Medical Research Center, Seoul National University, Seoul, Republic of Korea"},{"name":"Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea"},{"name":"Cancer Research Institute, Seoul National University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Woo","family":"Choi","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea"},{"name":"Department of Biomedical and Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea"},{"name":"Department of Pharmacology, Institute of Regulatory Innovation Through Science, Kyung Hee University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4714-1260","authenticated-orcid":false,"given":"Jung Pyo","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea"},{"name":"Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"issue":"5","key":"B1-20260826","doi-asserted-by":"crossref","first-page":"586","DOI":"10.23876\/j.krcp.23.156","article-title":"Pathogenesis and management of renal fibrosis induced by unilateral ureteral obstruction","volume":"43","author":"Nan","year":"2024","journal-title":"Kidney Res Clin Pract."},{"issue":"9","key":"B2-20260826","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41581-022-00590-z","article-title":"The fibrogenic niche in kidney fibrosis: components and mechanisms","volume":"18","author":"Li","year":"2022","journal-title":"Nat Rev Nephrol."},{"issue":"1","key":"B3-20260826","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s10020-023-00764-w","article-title":"The role of N-methyladenosine modification in acute and chronic kidney diseases","volume":"29","author":"Qi","year":"2023","journal-title":"Mol Med."},{"issue":"1","key":"B4-20260826","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13148-023-01586-7","article-title":"N6-methyladenosine methylation in kidney injury","volume":"15","author":"Wang","year":"2023","journal-title":"Clin Epigenetics"},{"issue":"3","key":"B5-20260826","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1021\/acs.jmedchem.2c01601","article-title":"METTL3 from target validation to the first small-molecule inhibitors: a medicinal chemistry journey","volume":"66","author":"Fiorentino","year":"2023","journal-title":"J Med Chem."},{"issue":"11","key":"B6-20260826","doi-asserted-by":"crossref","first-page":"102554","DOI":"10.1016\/j.jbc.2022.102554","article-title":"m6A RNA methylation regulates the transcription factors JUN and JUNB in TGF-\u03b2-induced epithelial\u2013mesenchymal transition of lung cancer cells","volume":"298","author":"Suphakhong","year":"2022","journal-title":"J Biol Chem."},{"issue":"8","key":"B7-20260826","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.7150\/ijbs.96233","article-title":"m6 A RNA methylation drives kidney fibrosis by upregulating \u03b2-catenin signaling","volume":"20","author":"Long","year":"2024","journal-title":"Int J Biol Sci."},{"issue":"2","key":"B8-20260826","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s12276-024-01159-5","article-title":"Targeting the m6A RNA methyltransferase METTL3 attenuates the development of kidney fibrosis","volume":"56","author":"Jung","year":"2024","journal-title":"Exp Mol Med."},{"issue":"12","key":"B9-20260826","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s13073-014-0095-1","article-title":"Systematic evaluation of connectivity map for disease indications","volume":"6","author":"Cheng","year":"2014","journal-title":"Genome Med."},{"issue":"2","key":"B10-20260826","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s13311-013-0255-9","article-title":"Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of machado-joseph disease","volume":"11","author":"Silva-Fernandes","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"9","key":"B11-20260826","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/cancers8090077","article-title":"Reduced contractility and motility of prostatic cancer-associated fibroblasts after inhibition of heat shock protein 90","volume":"8","author":"Henke","year":"2016","journal-title":"Cancers (Basel)."},{"issue":"12","key":"B12-20260826","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.devcel.2022.05.007","article-title":"PDGF signaling inhibits mitophagy in glioblastoma stem cells through N6-methyladenosine","volume":"57","author":"Lv","year":"2022","journal-title":"Dev Cell."},{"issue":"3","key":"B13-20260826","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","article-title":"The m6A methyltransferase METTL3 promotes translation in human cancer cells","volume":"62","author":"Lin","year":"2016","journal-title":"Mol Cell."},{"issue":"5","key":"B14-20260826","doi-asserted-by":"crossref","first-page":"314","DOI":"10.14366\/usg.24024","article-title":"Comprehensive sonographic evaluation of normal and fibrotic kidney in mouse model with ultra-high-frequency transducer","volume":"43","author":"Lee","year":"2024","journal-title":"Ultrasonography."},{"issue":"8","key":"B15-20260826","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1039\/C4CC07284G","article-title":"N-terminal and C-terminal modulation of Hsp90 produce dissimilar phenotypes","volume":"51","author":"Wang","year":"2015","journal-title":"Chem Commun (Camb)."},{"issue":"13","key":"B16-20260826","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1093\/nar\/gkg605","article-title":"Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN","volume":"31","author":"Farr\u00e9","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"B17-20260826","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/bioinformatics\/18.2.333","article-title":"PROMO: detection of known transcription regulatory elements using species-tailored searches","volume":"18","author":"Messeguer","year":"2002","journal-title":"Bioinformatics."},{"issue":"1","key":"B18-20260826","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1038\/s41467-020-16306-5","article-title":"N 6-methyladenosine regulates glycolysis of cancer cells through PDK4","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun."},{"issue":"9","key":"B19-20260826","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1158\/0008-5472.CAN-21-1323","article-title":"JNK signaling promotes bladder cancer immune escape by regulating METTL3-mediated m6A modification of PD-L1 mRNA","volume":"82","author":"Ni","year":"2022","journal-title":"Cancer Res."},{"issue":"1","key":"B20-20260826","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13046-021-01859-0","article-title":"HOXA10 mediates epithelial-mesenchymal transition to promote gastric cancer metastasis partly via modulation of TGFB2\/Smad\/METTL3 signaling axis","volume":"40","author":"Song","year":"2021","journal-title":"J Exp Clin Cancer Res."},{"issue":"11","key":"B21-20260826","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41419-022-05435-y","article-title":"HDAC1\/3-dependent moderate liquid\u2013liquid phase separation of YY1 promotes METTL3 expression and AML cell proliferation","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"B22-20260826","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/s41467-019-09712-x","article-title":"Excessive miR-25-3p maturation via N 6 -methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat Commun."},{"key":"B23-20260826","doi-asserted-by":"crossref","first-page":"155168","DOI":"10.1016\/j.prp.2024.155168","article-title":"Transcription factor RELA promotes hepatocellular carcinoma progression by promoting the transcription of m6A modulator METTL3","volume":"255","author":"Wu","year":"2024","journal-title":"Pathol Res Pract."},{"key":"B24-20260826","doi-asserted-by":"crossref","first-page":"131556","DOI":"10.1016\/j.jhazmat.2023.131556","article-title":"Cigarette smoking, by accelerating the cell cycle, promotes the progression of non-small cell lung cancer through an HIF-1\u03b1-METTL3-m6A\/CDK2AP2 axis","volume":"455","author":"Yang","year":"2023","journal-title":"J Hazard Mater."},{"issue":"39","key":"B25-20260826","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1038\/s41388-022-02435-2","article-title":"METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA","volume":"41","author":"Du","year":"2022","journal-title":"Oncogene."},{"issue":"6","key":"B26-20260826","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/ddr.22092","article-title":"The transcription factor ATF2 promotes gastric cancer progression by activating the METTL3\/cyclin D1 pathway","volume":"84","author":"Meng","year":"2023","journal-title":"Drug Dev Res."},{"issue":"1","key":"B27-20260826","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/s41467-022-28913-5","article-title":"Fusobacterium nucleatum reduces METTL3-mediated m6A modification and contributes to colorectal cancer metastasis","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun."},{"key":"B28-20260826","doi-asserted-by":"crossref","first-page":"155077","DOI":"10.1016\/j.tetlet.2024.155077","article-title":"Synthesis of STM2457, a selective small-molecule inhibitor of METTL3","volume":"141","author":"Zhu","year":"2024","journal-title":"Tetrahedron Lett."},{"issue":"8","key":"B29-20260826","first-page":"931","article-title":"Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice","volume":"8","author":"Singh","year":"2015","journal-title":"Dis Model Mech."},{"issue":"3","key":"B30-20260826","doi-asserted-by":"crossref","first-page":"e23458","DOI":"10.1096\/fj.202302160R","article-title":"GSK3\u03b2: a ray of hope for the treatment of diabetic kidney disease","volume":"38","author":"Liang","year":"2024","journal-title":"FASEB J."},{"issue":"2","key":"B31-20260826","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/bioinformatics\/btv536","article-title":"Drug-set enrichment analysis: a novel tool to investigate drug mode of action","volume":"32","author":"Napolitano","year":"2016","journal-title":"Bioinformatics."},{"issue":"2","key":"B32-20260826","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1021\/acschemneuro.7b00377","article-title":"Targeting heat shock protein 70 to ameliorate c-Jun expression and improve demyelinating neuropathy","volume":"9","author":"Zhang","year":"2018","journal-title":"ACS Chem Neurosci."},{"issue":"5","key":"B33-20260826","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/ndt\/gfad257","article-title":"Cell\u2013cell communication in kidney fibrosis","volume":"39","author":"He","year":"2024","journal-title":"Nephrol Dial Transplant."},{"issue":"3","key":"B34-20260826","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.kint.2016.08.025","article-title":"Progression of chronic kidney disease: too much cellular talk causes damage","volume":"91","author":"Gewin","year":"2017","journal-title":"Kidney Int."},{"issue":"11","key":"B35-20260826","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/labinvest.2012.127","article-title":"Heat shock protein 90 inhibitor attenuates renal fibrosis through degradation of transforming growth factor-\u03b2 type II receptor","volume":"92","author":"Noh","year":"2012","journal-title":"Lab Invest."},{"issue":"3","key":"B36-20260826","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1681\/ASN.2004050425","article-title":"Role of reactive oxygen species in TGF-\u03b21-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells","volume":"16","author":"Rhyu","year":"2005","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"B37-20260826","doi-asserted-by":"crossref","first-page":"713","DOI":"10.33594\/000000167","article-title":"Losartan through Hsp70 avoids angiotensin II induced mesenchymal epithelial transition in proximal tubule cells from spontaneously hypertensive rats","volume":"53","author":"Costantino","year":"2019","journal-title":"Cell Physiol Biochem."},{"issue":"3","key":"B38-20260826","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jgg.2011.02.001","article-title":"HSP70 decreases receptor-dependent phosphorylation of Smad2 and blocks TGF-\u03b2-induced epithelial-mesenchymal transition","volume":"38","author":"Li","year":"2011","journal-title":"J Genet Genomics."},{"issue":"4","key":"B39-20260826","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1681\/ASN.2009050552","article-title":"HSP72 inhibits Smad3 activation and nuclear translocation in renal epithelial-to-mesenchymal transition","volume":"21","author":"Zhou","year":"2010","journal-title":"J Am Soc Nephrol."},{"key":"B40-20260826","doi-asserted-by":"crossref","first-page":"2050183","DOI":"10.1155\/2019\/2050183","article-title":"Indoxyl sulfate induces renal fibroblast activation through a targetable heat shock protein 90-dependent pathway","volume":"2019","author":"Milanesi","year":"2019","journal-title":"Oxid Med Cell Longev."},{"issue":"5","key":"B41-20260826","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41419-021-03709-5","article-title":"Permissive effect of GSK3\u03b2 on profibrogenic plasticity of renal tubular cells in progressive chronic kidney disease","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"issue":"6","key":"B42-20260826","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.cmet.2021.03.024","article-title":"A methionine-Mettl3-N6-methyladenosine axis promotes polycystic kidney disease","volume":"33","author":"Ramalingam","year":"2021","journal-title":"Cell Metab."},{"issue":"10","key":"B43-20260826","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1681\/ASN.0000000000000428","article-title":"METTL3-mediated N6-methyladenosine mRNA modification and cGAS-STING pathway activity in kidney fibrosis","volume":"35","author":"Tsai","year":"2024","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"B44-20260826","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/s41596-023-00937-1","article-title":"GLORI for absolute quantification of transcriptome-wide m6A at single-base resolution","volume":"19","author":"Shen","year":"2024","journal-title":"Nat Protoc."},{"issue":"2","key":"B45-20260826","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41596-022-00765-9","article-title":"m6A-SAC-seq for quantitative whole transcriptome m6A profiling","volume":"18","author":"Ge","year":"2023","journal-title":"Nat Protoc."},{"issue":"2","key":"B46-20260826","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejca.2009.10.026","article-title":"Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies","volume":"46","author":"Kummar","year":"2010","journal-title":"Eur J Cancer."},{"issue":"6","key":"B47-20260826","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1158\/1078-0432.CCR-10-1927","article-title":"A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors","volume":"17","author":"Pacey","year":"2011","journal-title":"Clin Cancer Res."},{"issue":"6","key":"B48-20260826","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00280-005-1000-9","article-title":"Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance","volume":"56","author":"Glaze","year":"2005","journal-title":"Cancer Chemother Pharmacol."}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000000975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:05:50Z","timestamp":1787745950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000000975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.0000000975","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"2025-04-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}